Sensitivity, specificity and prognostic value of CEA in colorectal cancer : Results of a Tunisian series and review of literature;Sensibilite, specificite et valeur pronostique de l'ace dans LE cancer du colon rectum : Resultats d'une série Tunisienne et revue de la littérature

Tunisie Medicale

Volumn 79, Issue 8-9, 2001, Pages 434-440

  Bel Hadj Hmida, Youssef ^a   Tahri, Nabil ^b   Sellami, Ahmed ^c   Yangui, Nejah ^b   Jlidi, Rachid ^c   Beyrouti, Mohamed Issam ^d   Krichen, Mohamed Salah ^b   Masmoudi, Hatem ^a  

^a Laboratoire d'Immunologie   (Tunisia)

^b Service de Gastro Enterologie   (France)

^c Laboratoire d'Anatomie Pathologique   (France)

^d HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

CEA; Colo rectal carcinoma; Diagnosis; Sensitivity specificity

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; CANCER STAGING; CLINICAL TRIAL; COLORECTAL TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; METASTASIS; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; ENGLISH ABSTRACT; FEMALE; HUMAN; MALE; MIDDLE AGE; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 1842844928     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. GOLD P, FREEDMAN S. (1965). Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp Med. 121 : 439 - 462.
2. BURTIN P. (1980). Les antigènes carcinoembryonnaires. Path. Biol. 28, 8 : 489-492.
3. FLETCHER RH. (1986). Carcinoembryonic antigen. Ann Intern Med 104 : 66-73.
4. OBRINK B. (1997). CEA adhesion molecules : multifunctional proteins with signal-regulatory properties. Current Opinion in Cell Biology. 9 : 616-626.
5. HAMMARSTROM S. (1999). The Carcinoembryonic antigen (CEA) family : structures, suggested functions and expression in normal and malignant tissues. Seminars in Cancer Biology. 9 : 67-81.
6. MITCHELL EP. (1998). Role of carcinoembryonic antigen in the management of advanced colorectal cancer. Seminars in Oncology. Vol 25, 5 : 12-20.
7. MACDONALD JS. (1999). Carcinoembryonic antigen screening : Pros and Cons. Seminars in Oncology. Vol 26, 5 : 556-560.
8. STEVENS D.P, MACKAY I.R, CULLEN K.J. (1975). Carcinoembryonic antigen in an unselected elderly population : a four year follow up. Br. J. Cancer. 32 : 147-151.
9. BEATTY JD, ROMERO C, BROWN PW, LAWRENCE W JR, TERZ JJ. (1979). Clinical value of Carcinoembryonic antigen : diagnosis, prognosis, and follow-up of patients with cancer. Archives of Surgery. 114(5) : 563-7.
10. VAUTHEY JN, DUDRICK PS, LIND DS, COPELAND EM. (1996). Management of recurrent colorectal cancer : another look at carcinoembryonic antigen-detected recurrence. Digestive diseases. 14 : 5-13.
11. COSTANZA M.E. DAS S, NATHANSON L, RULE A, SCHWARTZ RS (1974). Carcinoembryonic antigen. Report of a Screening Study. Cancer. 33 : 583-590.
12. STEVENS DP, MACKAY IR, CULLEN KJ. (1975). Carcinoembryonic antigen in an unselected elderly population : A four-year follow up.Br. J. Cancer. 32 : 147-152.
13. WANG JY, TANG R, CHlANG JM. (1994). Value of carcinoembryonic antigen in the management of colorectal cancer (review) (23 refs). Diseases of the Colon & Rectum. 37(3) : 272-7.
14. PLEBANI M, DE PAOLI M, BASSO D et al (1996). Serum Tumor Markers in Colorectal Cancer Staging, Grading, and Follow-Up. Journal of Surgical Oncology. 62 :239-244.
15. LADENSON J, MCDONALD J, LANDI M, et al. (1980). Colorectal carcinoma and carcinoembryonic antigen (CEA). Clin Chem 26 : 1213-1220.
16. BALLESTA AM, MOLINA R, FILELLA X et al. (1995). Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol. 16 : 32-41.
17. NOVIS BH., GLUCK E, THOMAS P, et al. (1986).Serial levels of CA 19-9 and CEA in colonic cancer. Journal of clinical Oncology. 4(6) : 987-93.
18. PETERS KM, GRUNDMANN R. (1989). The value of tumor markers in colorectal cancer. Leber, Magen, Darm. 19(1:18-25.
19. GORGONE S, ALLERUZZO A, RIZZO AG et al. (1992).Tumor markers in colorectal cancer. Minerva Chirurgica. 47 (15-16) : 1249-52.
20. KOIZUMI F, ODAGIRI H, FUJIMOTO H, et al. (1992). Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer. Rinsho Byori - Japanese Journal of Clinical Pathology. 40 (5) : 523-8.
21. NISHIDA O, SHIROTO H, SATOH N, et al. (1988). Clinical evaluation of a combination assay of CEA, CA19-9 and TPA in patients with colorectal cancer. Gan No Rinsho-Japanese Journal of Cancer Clinics. 34(9) : 1096-100.
22. FERNANDEZ- FERNANDEZ -L, TEJERO E, TIESO A. (1995). Significance of CA72-4 in colorectal carcinoma. Comparison with CEA and CA19-9. Eur. J. Sur.Oncol. 21(4) : 388-90.
23. GUADAGNI F, ROSELLI M, COSIMELLI M, et al. (1993). TAG-72 (CA72-4 assay) as a complementary serum tumor antigen to carcino-embryonic antigen in monitoring patients with colorectal cancer. Cancer. 72(7) : 2098-106.
24. PUTZKI H, STUDENT A, JABLONSKI M, et al. (1987).Comparison of the tumor markers CEA, TPA, and CA19-9 in colorectal carcinoma. Cancer. 59(2) : 223-6.
25. OEHR P, DERIGS G, ALTMANN R. (1981). Evaluation and characterization of tumor-associated antigens by conversion of inverse distribution function values into specificity-sensitivity diagrams. Tumor diagnostik. 2 : 283-290.
26. LUTHGENS M, SCHLEGEL G. (1983). Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance. Cancer Detect Prev. 6 : 51-59.
27. CARRIQUIRY LA, PINEYRO A. (1999). Should carcinoembryonic antigen be used in the management of patients with colorectal cancer ? Diseases of the Colon & Rectum. 42 (7): 921-9.
28. ZAMCHECK N. (1976). A summary of the present status of CEA in diagnosis, prognosis and evaluation of therapy of colonic cancer. Bulletin du Cancer. t.63, 4 : 463-472.
29. NORTHOVER J (1995). The use of prognostic markers in surgery for colorectal cancer. European Journal of Cancer. Vol. 31A, Nos 7/8, 1207-1209.
30. FORONES NM, TANAKA M. (1999). CEA and CA19-9 as prognostic indexes in colorectal cancer. Hepato-Gastroenterology. 46(26) : 905-8.
31. CHAPMAN MA, BUCKLEY D, HENSON DB, et al. (1998).Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. British Journal of Cancer. 78(10) : 1346-9.
32. HERRERA MA, CHU TM, HOLYOKE ED. (1976). Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Annals of Surgery. 183(1) : 5-9.
33. LAVIN PT, DAY J, HOLYOKE ED et al. (1981). A statistical evaluation of baseline and follow-up carcinoembryonic antigen in patients with resectable colorectal carcinoma.Cancer. 47 (4) : 823-6. (4)
34. GOLDENBERG DM, NEVILLE AM, CARTER AC et al. (1981). CEA (carcinoembryonic antigen) : its role as a marker in the management of cancer. Journal of Cancer Research & Clinical Oncology. 101(3) : 239-42. (3)
35. AMERICAN SOCIETY OF CLINICAL ONCOLOGY (1996). Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Journal of Clinical Oncology. Vol 14, 10 : 2843-2877.
36. SLATER G, PAPATESTAS AE, AUFSES AH Jr. (1979). Preoperative carcinoembryonic antigen levels in colorectal carcinoma. Archives of Surgery. 114(1) : 52-3.
37. JIANG R. (1989). Clinical significance of serum CEA determination in the diagnosis of colo-rectal cancer. Chung-Hua Chung Liu Tsa Chih (Chinese Journal of Oncology). 11(5) : 348-51.
38. GOSLIN R, STEELE G, MACINTYRE J et al. (1980).The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg., 192(6) : 747-751.
39. WOLMARK N, FISHER B, WIEAND HS et al. (1984). The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Annals of Surgery. 199 (4) : 375-82.
40. CONROY T, GUILLEMlN F et al. (1994). Diagnostic et évaluation de l'extension des cancers colo-rectaux. La revue du praticien. 44 : 2706-2713.